2018
DOI: 10.1002/jper.18-0329
|View full text |Cite
|
Sign up to set email alerts
|

Reply from authors: RE: Optimized platelet‐rich fibrin with the low‐speed concept: Growth factor release, biocompatibility, and cellular response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 10 publications
(14 reference statements)
0
8
0
1
Order By: Relevance
“…PRF was thereafter developed as a second-generation platelet concentrate with the aim of anticoagulant removal [11]. This concentrate has frequently been termed leukocyte and platelet-rich fibrin (L-PRF) owing to the desired incorporation of leukocytes most commonly using a ~700 g for 12minute protocol [12]. Since anticoagulants are removed, blood is subject to clotting over time within the blood collection tube, and it therefore becomes critical that the treating clinician begin centrifugation shortly following blood collection to separate blood layers [13].…”
Section: Introductionmentioning
confidence: 99%
“…PRF was thereafter developed as a second-generation platelet concentrate with the aim of anticoagulant removal [11]. This concentrate has frequently been termed leukocyte and platelet-rich fibrin (L-PRF) owing to the desired incorporation of leukocytes most commonly using a ~700 g for 12minute protocol [12]. Since anticoagulants are removed, blood is subject to clotting over time within the blood collection tube, and it therefore becomes critical that the treating clinician begin centrifugation shortly following blood collection to separate blood layers [13].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, size of the rotor (radius at the clot and end of the tube); rotor angulation for the tube holder; revolutions per minute and time; structure and size of tubes used to produce PRF; and centrifugation model utilized must also be considered. This standardization was recently proposed and is a way to reduce bias in studies with PRF [32,33].…”
Section: Recommendations For Further Researchmentioning
confidence: 99%
“…PRF was thereafter developed as a second-generation platelet concentrate with the aim of anticoagulant removal [ 11 ]. This concentrate has frequently been termed leukocyte and platelet-rich fibrin (L-PRF) owing to the desired incorporation of leukocytes most commonly using a ~ 700 g for 12-min protocol [ 12 ]. Since anticoagulants are removed, blood is subject to clotting over time within the blood collection tube, and it therefore becomes critical that the treating clinician begin centrifugation shortly following blood collection to separate blood layers [ 13 ].…”
Section: Introductionmentioning
confidence: 99%